They Thought These Drugs Were About Food. They Are About Something Much Bigger.

A patient sat across from me recently and said something I have not been able to stop thinking about.

She had been on a GLP-1 medication for about six weeks. She was losing weight, but that was not why she was emotional. She wanted to talk about something else entirely.

The silence.

“I did not realize how loud it was,” she told me, “until it stopped.”

She was not describing noise in the room. She was describing the noise in her head. The constant, low-grade mental chatter about food — what she would eat, what she wanted, what she should not have, what she would allow herself later. A background hum so persistent she had stopped noticing it was there.

And then, almost overnight, it was gone.

I have been a psychiatrist for over fifteen years. I specialize in ADHD and mood disorders, and I have sat with thousands of patients describing relief. This was different. This was someone experiencing the sudden absence of something she had never been able to name.

She called it food noise.

The moment she said it, something clicked for me — because I had been hearing versions of that story from other patients for months. Not just about food. About alcohol. About compulsive scrolling. About impulsive spending. About behavioral loops they had been fighting their whole lives without ever being able to explain why the pull was so strong.

The medication had not just quieted her appetite.

It had turned down the volume on something much larger.

And as a psychiatrist who specializes in exactly this territory — and as someone who lives with ADHD herself — I think I know what that something is.

Food Noise Is Just the Beginning

Here's what most coverage of this phenomenon gets wrong: food is almost beside the point.

Food noise is not hunger. Hunger is physical — it rises, you eat, it resolves. Food noise is cognitive. It's the mental chatter that runs completely independent of physical need. The thoughts that surface again and again without invitation. The low-grade negotiation that never fully stops.

And it is not unique to food.

I see the same phenomenon in patients who can't stop thinking about their next drink. In patients who describe the urge to gamble as a physical presence in the room. In my ADHD patients who bounce from tab to tab — not because they want to be distracted, but because something in their brain keeps pulling them toward the next stimulus, and the next, and the next.

What strikes me is how consistent the language is across all of these patients. Different behaviors, different histories, different diagnoses — and yet they reach for the same words.

A noise. A pull. A hum that won't stop.

In my clinical work treating adults with ADHD, this pattern has come up again and again. I've come to think of it as reward noise — a term beginning to surface in neuroscience literature, though one that hasn't yet been fully formalized. It describes the persistent internal pull generated by a brain reward system running at a volume that's very difficult to override.

The Brain Behind the Pull

To understand why this matters, you need to understand what the brain's reward system actually does — because it's not just about pleasure.

The dopamine circuitry — centered in the ventral tegmental area, the nucleus accumbens, and the prefrontal cortex — is essentially your brain's relevance detector. It doesn't just make things feel good. It determines what feels important. What's worth your attention. What's worth pursuing right now versus later.

When this system is well calibrated, it works quietly in the background. You notice what matters, feel motivated to act, and can let less important stimuli fade.

When it's dysregulated — when the volume is turned up — everything changes. Certain stimuli start demanding attention in a way that's very hard to override. The pull toward food, alcohol, a screen, or a purchase stops feeling like a preference and starts feeling like a command.

This is what I mean by reward noise.

Here's what medicine has been slow to recognize, and what I see clearly in my practice every day: this is the same system failing across multiple conditions that we've historically treated as completely separate problems.

Obesity. Binge eating disorder. Addiction. Impulse control disorders. ADHD.

Different specialists. Different waiting rooms. Different treatment protocols.

But the same broken circuitry underneath — amplified, expressing itself through whatever behavior is most available, most reinforced, most culturally sanctioned for that particular person.

Different static. Same broken radio.

The Drug That Wasn't Supposed to Do This

GLP-1 medications — Ozempic, Wegovy, Mounjaro, Zepbound — were developed for metabolic disease. Blood sugar. Appetite. Weight.

Nobody designed them to be psychiatric medications.

But here's what researchers have discovered: GLP-1 receptors aren't only in the gut and pancreas. They're present in the brain's dopamine reward centers — the same regions involved in craving, motivation, and impulse control.

When these pathways are activated, something shifts. The brain's response to rewarding stimuli becomes quieter. Less urgent. More manageable.

My patients describe it with striking consistency:

One of my patients had struggled with binge eating for nearly twenty years. She had tried every behavioral intervention available. Within three weeks of starting a GLP-1 medication, she noticed something shift — not just around food, but in the quality of the pull she'd felt her entire life. It was quieter. More like a suggestion than a command.

She cried in my office. Not because of the number on the scale.

Because she finally understood that what she'd been fighting all these years wasn't a character flaw. It was a volume problem.

The ADHD Connection — and Why I Take This Personally

This is the part I want to slow down on, because it matters more than almost anything else being written about these medications right now — and almost nobody is discussing it the way I think it needs to be discussed.

ADHD is described as a disorder of attention. But that framing misses what's actually happening in the brain.

ADHD is, at its core, a disorder of reward processing.

I know this clinically. I also know it personally — because I have ADHD.

The dopamine signaling differences in ADHD don't simply make it hard to focus. They alter the entire experience of motivation and desire. Future rewards feel less compelling. Immediate rewards feel overwhelming. The brain's ability to say wait — to let something that matters later compete with something rewarding right now — is genuinely compromised. Not by a lack of willpower. Not by laziness. By the literal mechanics of how dopamine signals are processed in an ADHD brain.

My own medication manages somewhere between 50 and 65 percent of what needs managing. The rest is scaffolding — systems, structure, environmental design, and a great deal of deliberate effort every single day.

I know what it feels like to sit down to do important work and feel the pull toward something easier and more immediately rewarding — not because I want to be distracted, but because my brain is actively searching for the dopamine hit that the current task isn't delivering fast enough. I know the experience of a notification, an interesting idea, or a more pleasurable option entering my peripheral awareness and simply taking over. Not because I chose to let it. Because the pull was stronger than the intention.

That is the texture of reward dysregulation from the inside. And it is exhausting in a way that is genuinely hard to communicate to people whose reward systems don't run at this volume.

It also explains something I observe constantly in my practice: ADHD co-occurs at striking rates with binge eating, substance use disorders, compulsive spending, and impulsive behavior across virtually every domain. This is not coincidence. It's not random comorbidity. It's the same underlying biology expressing itself simultaneously across multiple areas of a person's life.

When my ADHD patients describe the exhaustion of fighting their own impulses — of having to work twice as hard to do what others seem to do automatically — they are describing what it means to navigate a world designed for people whose reward systems run at a different volume.

If GLP-1 medications are genuinely modulating reward salience — and the emerging evidence suggests they may be — they could be touching the same neural substrate that governs craving, impulsivity, and behavioral control across all of these presentations. Not just obesity. Not just food. All of it.

As someone who both treats and lives with this neurobiology, I find that possibility genuinely profound.

The Waiting Room Nobody Designed

Medicine has a compartmentalization problem that has never served patients well.

Obesity medicine speaks one language about food noise. Addiction psychiatry speaks a different language about cravings. ADHD research speaks yet another language about reward dysregulation. These fields developed largely in isolation, trained their specialists separately, and built their treatment systems in parallel silos.

But the patients I see don't arrive in neat categories.

They arrive with binge eating and impulsive spending. With substance use and distractibility. With a lifetime of feeling pulled toward things they don't entirely want, unable to understand why the pull is so much stronger for them than it appears to be for the people around them.

What these patients may share — what I believe connects all of these experiences at the biological level — is a reward system running at a volume that most people simply do not have to manage.

It is neuroscience.

What I Want You to Take From This

I want to be clear about what we know and what we don't — because intellectual honesty is the foundation of good medicine.

The evidence here is early. Much of it is observational. Patients are reporting changes that weren't the intended target of their treatment. Researchers are noticing patterns across clinical populations. The mechanistic picture is still being assembled. We do not yet have the randomized controlled trials that would allow us to speak with clinical certainty. I am not recommending GLP-1 medications for ADHD, addiction, or impulse control disorders. That is not where the evidence is.

But I have practiced long enough to know that patients often name things before science can explain them.

Food noise was a patient-generated term. No researcher coined it in a laboratory. People who lived with it found language for it — and only afterward did medicine begin to understand the biology underneath.

What I'm observing now, across my patient panel and in the broader clinical literature, feels like another moment of that kind. Patients describing the same unexpected quieting. The same loosened grip. The same lowered volume. Across conditions we've always treated as unrelated.

Something is being named.

It will mean that a drug developed to treat metabolic disease accidentally handed us a window into something fundamental:

Why do some brains demand certain things at full volume — while others can simply take them or leave them?

Why does the pull feel like a command for some people and a quiet suggestion for others?

Why does wanting feel, for certain people, more like being wanted by something?

I don't have the final answers yet. Neither does the science.

But I'm watching this space with genuine attention — and if I'm being honest, with something that feels a great deal like hope.

If this resonated, I write about the neuroscience of mental health, ADHD, and the biology of behavior. Share it with someone who needs the language.

Related Reading

This post has a direct companion piece: It Was Never About the Food, which applies the reward noise framework specifically to ADHD and binge eating — the neurochemical loop, the shame cycle, and what actually helps. If the ADHD section landed for you, that piece goes further.

About the Author

Dr. Dara Abraham, D.O.

Board-Certified Psychiatrist & Founder, Dr. Dara Psychiatry

Dr. Dara Abraham is a board-certified osteopathic psychiatrist specializing in Adult ADHD, Women's Mental Health, and Mood Spectrum Disorders. She founded Dr. Dara Psychiatry to provide the kind of personalized, unhurried psychiatric care she believes every patient deserves. She is a published contributor to ADDitude Magazine and Clinical Psychiatry News and writes regularly about the neuroscience of mental health, ADHD, and the biology of behavior.

View Full Bio@adultadhddrdaraLinkedIn